These antibodies also recognize pathological tau inclusions upon immunohistochemical examination; NFTs and glial and globose NFT inclusions in AD and PSP, respectively, were recognized by these antibodies in regions of pathological interest. This evidence concerns the gene MAPT and Alzheimer disease.